Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors

Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors

Adjuvant treatment with Imatinib is the standard of care for high-risk resected GISTs. Imatinib is known to have an impact on bone mineral density in patients affected by chronic myeloid leukemia, however this effect has never been investigated in GISTs.We retrospectively evaluated, on CT scans, the...

Full description

Bibliographic Details
Main Authors: Claudia Angela Maria Fulgenzi, Andrea Napolitano, Eliodoro Faiella, Laura Messina, Gennaro Castiello, Flavia Paternostro, Marianna Silletta, Francesco Pantano, Giuseppe Tonini, Daniele Santini, Bruno Vincenzi
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Journal of Bone Oncology
Subjects:
GISTs
Imatinib
Bone mineral density
Muscle composition
Imatinib-related toxicities
Online Access:http://www.sciencedirect.com/science/article/pii/S2212137422000124

Internet

http://www.sciencedirect.com/science/article/pii/S2212137422000124

Similar Items